After Dropping AstraZeneca From Its Vaccine Plan, the Africa CDC Looks to Sinopharm For Jabs
The Africa Center for Disease Control is reportedly in “advanced stage of discussions” to secure supplies of the Chinese-made Sinopharm vaccine. “We are hopeful the discussion will lead to a favorable pronouncement on the emergency use authorization of Sinopharm’s coronavirus vaccine. This will increase the pool of our recommended vaccines,” said Dr. John Nkengasong, the director of the Africa CDC at a press briefing late last week.
- Get a daily email packed with the latest China-Africa news and analysis.
- Read exclusive insights on the key trends shaping China-Africa relations.
- Connect with leading professionals on the China- Africa Experts Network.
You’ve reached your free monthly article limit.
Subscribe today for unlimited access.
The post After Dropping AstraZeneca From Its Vaccine Plan, the Africa CDC Looks to Sinopharm For Jabs appeared first on The China Africa Project.
source https://chinaafricaproject.com/2021/04/26/after-dropping-astrazeneca-from-its-vaccine-plan-the-africa-cdc-looks-to-sinopharm-for-jabs/
Comments
Post a Comment